Effect of inhaler salbutamol versus placebo on treatment of neonatal transient tachypnea
Phase 2
Recruiting
- Conditions
- eonatal transient tachypnea.Transient tachypnoea of newborn
- Registration Number
- IRCT201711139014N201
- Lead Sponsor
- Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Age of 34 to 47 weeks; neonatal transient tachypnea.
Exclusion criteria: Pneumothorax; maternal addiction; respiratory distress syndrome; meconium aspiration; pneumonia; sepsis; congenital heart disease; pulmonary hypertension.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of breathing. Timepoint: Before and 0.5, 1 and 4 hours after treatment. Method of measurement: By physical examination.;TTN clinical score. Timepoint: Before and 0.5, 1 and 4 hours after treatment. Method of measurement: By physical examination.;Arterial oxygen saturation. Timepoint: Before and 4 hours after treatment. Method of measurement: By checking arterial blood sample.
- Secondary Outcome Measures
Name Time Method